tiprankstipranks
Dr. Hoenle AG (CH:HNL)
:HNL

Dr. Hoenle AG (HNL) Price & Analysis

0 Followers

HNL Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
TTM Revenue ReboundThe sharp TTM revenue rebound indicates renewed demand for the company’s UV and LED industrial solutions. If sustained across end markets, higher sales can improve operating leverage and support a broader recovery in profitability.
Positive Cash GenerationPositive operating and free cash flow provides internal funding for operations, product development and customer support. This reduces reliance on external financing, although the durability of cash generation still depends on improving earnings quality.
Manageable LeverageModerate leverage and a substantial equity base provide financial flexibility during the turnaround. The balance sheet does not appear distressed, giving management capacity to invest in UV/LED systems and withstand uneven industrial demand.
Bears Say
Severe Gross Margin PressureThe collapse in gross margin shows that higher revenue has not translated into equivalent economic value. Unless pricing, product mix or production efficiency improves, weak gross profitability will constrain operating leverage and sustainable earnings.
Persistent UnprofitabilityOngoing losses and negative returns on equity indicate that the revenue recovery has not yet produced a durable business-level return. Continued unprofitability can restrict reinvestment capacity and weaken shareholder value creation over time.
Volatile Cash ConversionRecent positive cash flow is encouraging, but the history of weak or negative cash generation suggests limited consistency. Volatile conversion makes planning and funding investment more difficult until profitability and working-capital performance normalize.

Dr. Hoenle AG News

HNL FAQ

What was Dr. Hoenle AG’s price range in the past 12 months?
Currently, no data Available
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is CHF43.74M.
    When is Dr. Hoenle AG’s upcoming earnings report date?
    Dr. Hoenle AG’s upcoming earnings report date is Dec 08, 2026 which is in 85 days.
      How were Dr. Hoenle AG’s earnings last quarter?
      Dr. Hoenle AG released its earnings results on Aug 18, 2026. The company reported -CHF0.035 earnings per share for the quarter.
        Is Dr. Hoenle AG overvalued?
        According to Wall Street analysts Dr. Hoenle AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dr. Hoenle AG pay dividends?
          Dr. Hoenle AG does not currently pay dividends.
          What is Dr. Hoenle AG’s EPS estimate?
          Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Dr. Hoenle AG have?
          Dr. Hoenle AG has 6,062,930 shares outstanding.
            What happened to Dr. Hoenle AG’s price movement after its last earnings report?
            Dr. Hoenle AG reported an EPS of -CHF0.035 in its last earnings report. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Dr. Hoenle AG?
              Currently, no hedge funds are holding shares in CH:HNL
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Dr. Hoenle AG Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -7.80%
                12-Months-Change

                Fundamentals

                Return on Equity
                Trailing 12-Months
                Asset Growth
                -4.48%
                Trailing 12-Months
                Learn more about TipRanks Smart Score

                Company Description

                Dr. Hoenle AG

                Dr. Hönle AG is a global provider specializing in industrial ultraviolet (UV) technologies and related systems, with operations spanning Germany and international markets. The company organizes its business into three main segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives division develops industrial bonding solutions for critical applications within sectors such as consumer electronics, medical technology, optics and opto-electronics, the automotive industry, and glass processing. Its Equipment & Systems segment focuses on developing solutions for the efficient drying of inks and coatings, the precise curing of adhesives and plastics, comprehensive surface disinfection, and advanced solar simulation. Lastly, the Glass & Lamps division manufactures quartz glass tubing and rods, which are vital for the lamp, automotive, semiconductor, and fiber optic cable industries, alongside producing specialized lamps utilized for water purification and the drying of various coatings and adhesives. Founded in 1976, Dr. Hönle AG is headquartered in Munich, Germany.

                Dr. Hoenle AG (HNL) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                LPKF Laser & Electronics
                Manz AG
                MAX Automation
                Singulus Technologies
                Suss Microtec
                Popular Stocks